Chemotherapy News and Research

Latest Chemotherapy News and Research

Thalidomide may be a potent anti-cancer treatment

When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment.

20 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

Monitoring and fine tuning the levels of the cancer drug topotecan in children with neuroblastoma holds promise for maximizing the drug's effectiveness while reducing its toxicity, according to investigators at St. Jude Children's Research Hospital.

19 Jun 2005

Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia

While more than 70% of patients survive childhood leukemia, curative chemotherapy can often irreversibly impair the formation of spermatozoa, causing infertility in males.

16 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

16 Jun 2005

MRI measurement of breast tumor volume predicts whether a patient's cancer will return

The study, performed at the University of California-San Francisco, of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).

16 Jun 2005

Doctor blames parents for return of sick girl's cancer

Thirteen year old Katie Wernecke is back in hospital after doctors confirmed the girls Hodgkin's disease had returned.

16 Jun 2005

FDA approves Xeloda (capecitabine) oral chemotherapy

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) -- an innovative oral chemotherapy -- for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.

15 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

Research urges a new approach to cancer detection

A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.

14 Jun 2005

Chemokine Therapeutics granted new U.S patent

Chemokine Therapeutics has announced that it has been granted U.S. Patent No. 6,875,738 relating to the use of its anti-cancer compound, CTCE-9908, in the treatment of cancer and inhibition of angiogenesis. CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells.

14 Jun 2005

Overweight and obese women with breast cancer may be undertreated

Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.

13 Jun 2005

Chemotherapy for brain tumors is boosted after vaccine targets resistance-related TRP-2 antigen

In the August issue of the journal Oncogene, researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute describe a molecular mechanism that appears to make malignant brain tumors more vulnerable to chemotherapy after they have been treated with the dendritic cell vaccine.

13 Jun 2005

Novel and more effective way of testing which gene mutations cause cancer

Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that's the hope.

12 Jun 2005

Half of 580 women diagnosed with breast cancer in one study experienced lymphedema

The good news is that there are nearly two million breast cancer survivors in the United States , and survival rates continue to increase for patients with this disease. But the flip side is that survival can present its own set of little-known complications.

12 Jun 2005

Texas girl with Hodgkin's sees return of the disease- treatment to go ahead

12-year old Katie Wernecke, the child at the centre of a nasty court battle between her parents and state officials, has seen a return of the Hodgkin's cancer her parents have tried to resist having treated by radiation therapy.

12 Jun 2005

Experts call for more research into treatments for children's brain tumours

More independent study is needed into the biology of children's brain tumours if effective treatments are to be developed, experts at The University of Nottingham have said in a leading journal.

10 Jun 2005

Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance

Using targeted RNA interference, or RNAi libraries, researchers at Harvard Medical School describe the first large-scale classification of kinase and phosphatase gene families on the basis of their role in apoptosis and cell survival. This study appears in the June issue of Nature Cell Biology.

10 Jun 2005

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Schering-Plough announced today that the European Commission has granted approval of Temodal (temozolomide) Capsules for first-line use for the treatment of patients with newly diagnosed glioblastoma multiforme (GBM), the most common and aggressive form of primary brain cancer.

10 Jun 2005

Exercise helps recovery after chemotherapy for breast cancer

Exercise after chemotherapy for breast cancer boosted the activity of infection-fighting T cells in women who worked out regularly, according to data from a study conducted at Penn State University under the direction of Andrea Mastro, professor of microbiology and cell biology.

10 Jun 2005

Molecule called Smad7 may open doors to future treatments in pancreatic and other forms of cancer

Making new strides in their ongoing effort to understand mechanisms behind the relentless growth of cancer cells, researchers at Dartmouth Medical School have found a promising key that may open doors to future treatments in pancreatic and other forms of cancer.

9 Jun 2005

Chemotherapy News and Research

Latest Chemotherapy News and Research

Thalidomide may be a potent anti-cancer treatment

Fine tuning drug levels in neuroblastoma patients is effective

Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia

Fine tuning drug levels in neuroblastoma patients is effective

MRI measurement of breast tumor volume predicts whether a patient's cancer will return

Doctor blames parents for return of sick girl's cancer

FDA approves Xeloda (capecitabine) oral chemotherapy

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

Research urges a new approach to cancer detection

Chemokine Therapeutics granted new U.S patent

Overweight and obese women with breast cancer may be undertreated

Chemotherapy for brain tumors is boosted after vaccine targets resistance-related TRP-2 antigen

Novel and more effective way of testing which gene mutations cause cancer

Half of 580 women diagnosed with breast cancer in one study experienced lymphedema

Texas girl with Hodgkin's sees return of the disease- treatment to go ahead

Experts call for more research into treatments for children's brain tumours

Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Exercise helps recovery after chemotherapy for breast cancer

Molecule called Smad7 may open doors to future treatments in pancreatic and other forms of cancer

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in